Skip to main content
ISR-2015-year-in-review-infographic-Dec2015-tnail

The first biosimilar approved in the United States, debate around drug pricing, financial growth, and several noteworthy partnerships and mergers — these were just a few of the highlights from the clinical development and manufacturing industries in 2015.

View Resource